These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22298790)

  • 1. Sustained response to tocilizumab, anti-IL-6 antibody, following anti-TNF-α failure in a patient with relapsing polychondritis complicated by aortitis.
    Narshi CB; Allard SA
    Rheumatology (Oxford); 2012 May; 51(5):952-3. PubMed ID: 22298790
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained response to tocilizumab in a patient with relapsing polychondritis complicated by aortitis.
    Sallés M; Mínguez S; Ros S; Tuneu R; Gelman SM
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):223. PubMed ID: 28229816
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged response to anti-tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis.
    Seymour MW; Home DM; Williams RO; Allard SA
    Rheumatology (Oxford); 2007 Nov; 46(11):1738-9. PubMed ID: 17933796
    [No Abstract]   [Full Text] [Related]  

  • 4. Sustained response to tocilizumab in a patient with relapsing polychondritis with aortic involvement: a case based review.
    Stael R; Smith V; Wittoek R; Creytens D; Mielants H
    Clin Rheumatol; 2015 Jan; 34(1):189-93. PubMed ID: 24831688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapsing polychondritis: response to tocilizumab and association with colitis.
    Plunkett M; Lamont D; Brooker J; White D
    J Clin Rheumatol; 2013 Oct; 19(7):415-7. PubMed ID: 24048111
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of adalimumab for a refractory case of relapsing polychondritis with reduction of pro-inflammatory cytokines.
    Nakamura H; Suzuki T; Nagaoka K; Yamasaki S; Tamai M; Hayashi T; Kawakami A
    Mod Rheumatol; 2011 Dec; 21(6):665-8. PubMed ID: 21509650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis.
    Elourimi G; Soussan M; Warzocha U; Bugaud H; Dhôte R; Abad S
    Rheumatol Int; 2017 Nov; 37(11):1931-1935. PubMed ID: 28965131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of relapsing polychondritis with tocilizumab.
    Wendling D; Godfrin-Valnet M; Prati C
    J Rheumatol; 2013 Jul; 40(7):1232. PubMed ID: 23818726
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of tocilizumab therapy in a patient with mouth and genital ulcers with inflamed cartilage syndrome complicated by aortic aneurysm.
    Terreaux W; Mestrallet S; Fauconier M; Pennaforte JL; Penalba C; Eschard JP; Salmon JH
    Rheumatology (Oxford); 2015 Nov; 54(11):2111-3. PubMed ID: 26175469
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sustained response with tocilizumab in a case of refractory relapsing polychondritis].
    Weber E; Gaultier JB; Paul S; Guichard I; Monard E; Cathébras P
    Rev Med Interne; 2014 Mar; 35(3):196-8. PubMed ID: 24074969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis.
    Kawai M; Hagihara K; Hirano T; Shima Y; Kuwahara Y; Arimitsu J; Narazaki M; Ogata A; Kawase I; Kishimoto T; Tanaka T
    Rheumatology (Oxford); 2009 Mar; 48(3):318-9. PubMed ID: 19106169
    [No Abstract]   [Full Text] [Related]  

  • 12. Refractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade.
    Wallace ZS; Stone JH
    J Rheumatol; 2013 Jan; 40(1):100-1. PubMed ID: 23280172
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment with tocilizumab for refractory scleritis associated with relapsing polychondritis.
    Shimizu H; Nishioka H
    Scand J Rheumatol; 2017 Sep; 46(5):418-419. PubMed ID: 28120637
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatal acute necrotizing eosinophilic myocarditis temporally related to use of adalimumab in a patient with relapsing polychondritis.
    Adamson R; Yazici Y; Katz ES; Greisman SG; Steiger D
    J Clin Rheumatol; 2013 Oct; 19(7):386-9. PubMed ID: 24048108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with tocilizumab in a case of Cogan's syndrome complicated with aortitis.
    Shibuya M; Fujio K; Morita K; Harada H; Kanda H; Yamamoto K
    Mod Rheumatol; 2013 May; 23(3):577-81. PubMed ID: 22752533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained remission of pediatric relapsing polychondritis with adalimumab.
    Navarrete VM; Lebrón CV; de Miera FJ; Candau CP; Sarabia FN
    J Clin Rheumatol; 2014 Jan; 20(1):45-6. PubMed ID: 24356482
    [No Abstract]   [Full Text] [Related]  

  • 17. Sustained Remission with Tocilizumab in Refractory Relapsing Polychondritis with Ocular Involvement: A Case Series.
    Farhat R; Clavel G; Villeneuve D; Abdelmassih Y; Sahyoun M; Gabison E; Sené T; Cochereau I; Titah C
    Ocul Immunol Inflamm; 2021 Jan; 29(1):9-13. PubMed ID: 32643976
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of tocilizumab for psychiatric symptoms associated with relapsing polychondritis: the first case report and review of the literature.
    Liu L; Liu S; Guan W; Zhang L
    Rheumatol Int; 2016 Aug; 36(8):1185-9. PubMed ID: 27260262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dr. Wallace and Dr. Stone reply.
    Wallace ZS; Stone JH
    J Rheumatol; 2013 Jul; 40(7):1232. PubMed ID: 23980261
    [No Abstract]   [Full Text] [Related]  

  • 20. Sweet's syndrome after adalimumab therapy for refractory relapsing polychondritis.
    Keidel S; McColl A; Edmonds S
    BMJ Case Rep; 2011 Dec; 2011():. PubMed ID: 22670004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.